Featured sessions

The program will be updated regularly.

Plenary sessions

Education sessions

Science-in-Focus

Hematology-in-Focus

SWG sessions

Thematic days

Spotlight talks (New Session Format)

Thematic debates (New Session Format)

Guidelines Sessions (New Session Format)

Joint Symposia

Workshops

Advocacy & Patient Sessions

All sessions will take place in Central European Summer Time (CEST).

Plenary Sessions

The Plenary Sessions will be held live on Friday, June 11 & Saturday, June 12.

Plenary Sessions are composed of outstanding speakers presenting on a topic of general interest.

Plenary Session I

  • Spliceosome in cancer
    O Abdel-Wahab (United States)
  • Innovative treatments for rare anemias
    MD Cappellini (Italy)

Plenary Session II

  • CAR NK Cells: Can they compete with CAR-T cell therapy?
    Speaker to be announced
  • Functional consequences of mutations in MPN
    S Constantinescu (Belgium)
  • Physiopathology of Coagulopathy in hematological malignancies and in COVID-19
    M Levi (United Kingdom)

Thematic Days

The Thematic Days will be held between Sunday, June 13 and Thursday, June 17 and will include Live Q&A Sessions and New Session Formats.

  • Sunday, June 13
    • Immunology
    • Lymphoma
  • Monday, June 14
    • Chronic lymphoid neoplasms
    • Thrombosis & hemostasis
  • Tuesday, June 15
    • Red and white cell disorders
  • Wednesday, June 16
    • Chronic myeloid malignancies
  • Thursday, June 17
    • Acute leukemia

List of themes

  • Acute leukemia
  • Chronic myeloid neoplasms
  • Chronic lymphoid neoplasms
  • Immunology
  • Lymphoma
  • Red and white cell disorders
  • Thrombosis & hemostasis

Education Sessions

The Education Sessions will be released as on-demand content on Friday, June 11 at 09:00 CEST. The Live Q&A Sessions will be held between Sunday, June 13 and Thursday, June 17 on dedicated Thematic Days.

Education Sessions concentrate on one topic and follow the same scheme. The first speaker gives information on basic principles and mechanisms, the second speaker on translational research and the third on clinical aspects. This format has been introduced to attract both basic researchers and clinicians to the same session.

  • Crossroads of coagulation, inflammation and fibrinolysis
  • Follicular lymphoma and GC neoplasia
  • Genomics & treatment of MPN
  • Hemoglobinopathies: What we know and where we head
  • Immunotherapeutic targeting in AML
  • Immunotherapy in myeloma
  • Inherited and acquired hemostasis defects
  • Platelets
  • Prevention of GvHD in allogeneic stem cell transplantation
  • Refractory DLBCL
  • Relapsed Hodgkin lymphoma
  • Sickle cell disease (SCD)
  • Standard- vs high-risk chronic lymphocytic leukemia in the novel agent era
  • Stem cells targeting in CML
  • T-ALL
  • Targeting high-risk AML
  • Targeting low-risk MDS
  • Transfusion

Science-in-Focus Sessions

The Science-in-Focus Sessions will be released as on-demand content on Friday, June 11 at 09:00 CEST. The Live Q&A Sessions will be held between Sunday, June 13 and Thursday, June 17 on dedicated Thematic Days.

Science-in-Focus sessions zoom in on very specific topics in basic research and are intended mainly for basic and translational researchers.

  • AML vulnerabilities
  • Clonal lymphopoiesis
  • How and why do cells migrate?
  • Iron & immunity
  • Megakaryopoiesis and platelets
  • New insights into the biological mechanisms and therapy of B cell malignancies
  • Pathophysiology of inflammatory disorders
  • Preleukemic mutations & progression

Hematology-in-Focus Sessions

The Hematology-in-Focus Sessions will be released as on-demand content on Friday, June 11 at 09:00 CEST. The Live Q&A Sessions will be held between Sunday, June 13 and Thursday, June 17 on dedicated Thematic Days.

Hematology-in-Focus sessions concentrate on a hot scientific or clinical topic in any field of hematology. These sessions are designed to look at one topic in-depth, rather than the broader overview provided in Education Sessions.

  • AL amyloidosis
  • Cancer and thrombosis
  • Near future in HR-MDS treatment
  • Targeted therapies in AML
  • What we have learned about mature T-cell leukemia (T-PLL and T-LGLL)

Scientific Working Group Sessions

The Scientific Working Group Sessions will be released as on-demand content on Friday, June 11 at 09:00 CEST. The Live Q&A Sessions will be held between Sunday, June 13 and Thursday, June 17 on dedicated Thematic Days.

SWG Sessions are organized by the EHA Scientific Working Groups, which are active networks of researchers and clinicians. The sessions highlight research coming out of each working group.

  • Acute myeloid leukemia (AML) & Myelodysplastic syndromes (MDS): Targeting TP53 in MDS/AML
  • Aging and hematology: Telemedicine in vulnerable older adults with hematological malignancies in the time of COVID-19
  • Bleeding and thrombosis: Bleeding and thrombosis: New insights into mechanisms and management of sepsis-induced DIC
  • Diagnosis in hematological diseases: Morphology and flow cytometry
  • EHA Lymphoma Group: Current and future treatment of mantle cell lymphoma
  • ELN-EHA SWG for CML: ELN-EHA SWG for CML: Chronic myeloid leukemia
  • European Research Initiative on CLL (ERIC): Challenges in the treatment of CLL
  • European Working Group on Adult ALL (EWALL)
  • Genetic predisposition hematologic cancer (rare diseases): Mechanisms of transformation: Insights from genetic predisposition disorders
  • Granulocytes & constitutional marrow failure disorders: New insights in granulocytes and constitutional marrow failures disorders
  • Immune therapies for hematologic disorders: CAR T-cells versus T-cell engaging antibodies
  • Infections in hematology: The critically ill patient during the pandemic
  • Mesenchymal stem cells (MSC): Mesenchymal stromal cells and COVID-19
  • Multiple myeloma: What is high-risk disease in the era of modern agents?
  • Myeloproliferative neoplasms (MPN)
  • Pediatrics: Macrophages and histiocytes
  • Precision hematology: Integration of functional approaches in precision hematology
  • Quality of life and symptoms
  • Red cells and iron: Novel therapies in hemoglobin induction
  • Stem cells: HSC during ageing and stress
  • Thrombocytopenias and platelet function disorders: Platelet disorders: Open questions
  • Transfusion: Pediatric transfusion practice: Children are not little adults

Joint Symposia

The Joint Symposia will be held live on Friday, June 11 and Saturday, June 12.

Joint Symposia demonstrate EHA’s connections with well-known societies in- and outside of Europe. The topic of the symposium can be scientific or educational, but also political or any other aspect important to the professional and medical development of hematologists. More symposia will be added at a later stage.

  • EHA-ASH Joint Symposium
  • EHA-JSH Joint Symposium
  • EHA-EBMT Joint Symposium
  • EHA-ISEH Joint Symposium
  • EHA-ESH Joint Symposium

Workshops

  • EHA-ISLH Laboratory Diagnosis Workshop
  • Molecular Hemopoiesis Workshop
  • Lymphoid Biology and Malignancy Workshop